8-KRegulation FDExhibits & Filings

CARDINAL HEALTH INC 8-K Report, Regulation FD Disclosure (Jan 10, 2022)

Filed January 10, 2022For Securities:CAH

Summary

Cardinal Health Inc. (CAH) filed an 8-K on January 10, 2022, primarily to announce a significant update to their previously issued fiscal year 2022 Medical segment profit expectations. This revision is expected to have a related impact on the company's non-GAAP earnings per share for the fiscal year. The announcement was made via a press release, which is included as an exhibit to this filing. Investors should pay close attention to the specific details of this profit expectation update as it directly affects the company's forward-looking financial performance guidance.

Key Highlights

  • 1Cardinal Health announced an update to its fiscal year 2022 Medical segment profit expectations.
  • 2The revision in Medical segment profit will impact the company's non-GAAP earnings per share (EPS) for fiscal year 2022.
  • 3The company did not provide specific new profit numbers or EPS guidance in the 8-K itself, but referred to an attached press release for details.
  • 4The filing includes a press release dated January 10, 2022, which contains the detailed announcement.
  • 5Cardinal Health also mentioned its upcoming participation in the 40th Annual J.P. Morgan Healthcare Conference.
  • 6The 8-K filing is categorized under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose an updated profit expectation for Cardinal Health's Medical segment for fiscal year 2022, and its expected impact on the company's non-GAAP earnings per share. This information was shared via a press release.

The detailed information regarding the updated Medical segment profit expectations and the related impact on non-GAAP EPS for fiscal year 2022 is provided in the press release issued by Cardinal Health on January 10, 2022, which is attached as Exhibit 99.1 to this 8-K filing.

This 8-K filing specifically focuses on an update to the Medical segment's profit expectations and its impact on non-GAAP EPS. It does not appear to provide updated guidance for other segments or overall company financial performance beyond what is discussed in relation to the Medical segment update.

Yes, the press release referenced in the 8-K also mentions that Cardinal Health will be participating in the 40th Annual J.P. Morgan Healthcare Conference.